Mads Krogsgaard T
Bio-Pharmaceuticals
Nova
Ireland
Biography
Mads Krogsgaard Thomsen joined Novo Nordisk in 1991 as head of Growth Hormone Research. Following that he directed Diabetes R&D and Global Drug Discovery, and in November 2000 he was appointed executive vice president and chief science officer. In this role, he is responsible for global drug and device research, development, medical affairs, regulatory and safety within Novo Nordisk.
Research Interest
Bio-Pharmaceuticals
